4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000183
Chairperson & CEO sold 9,500 shares at an average $564.51 ($5,362,824)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-11-06 | Sale : show line 2 in the form 10b5-1 | −109 | $560.79 | $61,126 | 333,834 | I |
| 2026-11-06 | Sale : show line 3 in the form 10b5-1 | −2,005 | $561.80 | $1,126,406 | 331,829 | I |
| 2026-11-06 | Sale : show line 4 in the form 10b5-1 | −1,136 | $562.87 | $639,419 | 330,693 | I |
| 2026-11-06 | Sale : show line 5 in the form 10b5-1 | −870 | $563.85 | $490,551 | 329,823 | I |
| 2026-11-06 | Sale : show line 6 in the form 10b5-1 | −1,776 | $564.99 | $1,003,414 | 328,047 | I |
| 2026-11-06 | Sale : show line 7 in the form 10b5-1 | −1,742 | $565.85 | $985,707 | 326,305 | I |
| 2026-11-06 | Sale : show line 8 in the form 10b5-1 | −1,021 | $566.83 | $578,733 | 325,284 | I |
| 2026-11-06 | Sale : show line 9 in the form 10b5-1 | −761 | $567.64 | $431,973 | 324,523 | I |
| 2026-11-06 | Sale : show line 10 in the form 10b5-1 | −80 | $568.68 | $45,494 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $564.51 · $5,362,824 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-06 | Exercise or conversion : show line 11 in the form 10b5-1 Stock Option | −9,500 | 71,910 | I |
Loading xslF345X06/primarydocument.xml…